Target intelligence / Profile preview

Periaxin (PRX)

Target
PRX
Molecular classification
Other (Scaffolding protein; not a classical receptor, enzyme, ion channel, transporter, or transcription factor. Contains PDZ domain, found in supramolecular complexes)
01

Overview

Periaxin is a scaffolding protein encoded by the PRX gene, primarily expressed in Schwann cells of the peripheral nervous system and also in eye lens fiber cells. It forms part of the dystroglycan–dystrophin-related protein complex, providing a structural link between the Schwann cell cytoskeleton and the extracellular matrix, crucial for maintaining the stability, thickness, and long-term integrity of the myelin sheath around axons. Periaxin has two main isoforms (L-periaxin and S-periaxin) generated by alternative mRNA splicing; L-periaxin is essential for the maintenance of myelin, whereas S-periaxin has more general cytoplasmic and nuclear localization within Schwann cells. Genetic defects in the PRX gene are associated with demyelinating neuropathies, namely Charcot–Marie–Tooth disease type 4F (CMT4F) and Dejerine–Sottas disease, leading to progressive peripheral nerve dysfunction. Recent studies also indicate a role for periaxin in endothelial cell barrier function in humans, suggesting possible roles beyond the peripheral nervous system. At present, periaxin is not a direct drug target.

Other names
PeriaxinPRXKIAA1620CMT4F
02

Biological functions

Myelin maintenance in the peripheral nervous systemFormation and stabilization of the peripheral myelin sheathSchwann cell elongation and myelin internode formationRegulation of myelin sheath thicknessFormation of Cajal bands and Schmidt-Lanterman incisuresEye lens cell scaffold functionModulation of endothelial barrier function (in human cerebral endothelial cells)
03

Disease associations

Neurodegenerative disease (Charcot–Marie–Tooth disease, CMT4F)Demyelinating neuropathies (Dejerine–Sottas disease)Cataracts (age-related cataracts with certain variants)

Beyond the preview

Go deeper on Periaxin (PRX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Periaxin (PRX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call